Hudson Innovations' Past Activities
News - Archive
March 1, 2014. Eva B. Schadeck, M.Sc., PhD. joins B D Forrest & Company, Inc. as Chief Research Officer.
Presentations
Tokyo, January 26, 2011. Bruce D. Forrest, MD, President, B D Forrest & Company, Inc. of New York, is Co-Chairman and Keynote Speaker at the International Chamber of Innovation, Commerce & Enterprise (ICICE)-organized BIO Asia 2011 sidebar workshop, “Advancing a Framework: Building an International Model for Japan Bioventures” at the Japan National Diet House of Representatives, Tokyo, Japan.
Transactions
January 13, 2012. Nuron Biotech, Inc. and Mitsubishi Tanabe Pharma Corp. of Japan announce licensing of pediatric vaccine HibTITER® in transaction facilitated by B D Forrest & Company, Inc.
Partnering & Licensing
December 3, 2013. B D Forrest & Company, Inc. and Pennsylvania-based Paradiso Biologics Consulting, LLC. execute a strategic alliance agreement to offer clients expanded services in the field of pharmaceutical licensing.
August 1, 2013. B D Forrest & Company, Inc. executes pharmaceutical licensing facilitation agreement with Seryx Biomedical, Inc.
July 29, 2013. B D Forrest & Company, Inc. executes medical technology licensing facilitation agreement with Enigma Medical, Inc.
May 15, 2013. B D Forrest & Company, Inc. executes pharmaceutical licensing facilitation agreement with Astuce, Inc.
February 20, 2013. B D Forrest & Company, Inc. and Pennsylvania-based Philimmune, LLC. execute a strategic alliance agreement to offer clients expanded services in the field of pharmaceutical licensing.
October 4, 2012. B D Forrest & Company, Inc. executes pharmaceutical licensing agreement with Omni Bio Pharmaceutical, Inc.
June 25, 2012. B D Forrest & Company, Inc. executes pharmaceutical licensing agreement with Sarentis, Inc.
June 12, 2012. B D Forrest & Company, Inc. executes pharmaceutical licensing agreement with Integrated BioTherapeutics, Inc.
March 28, 2012. B D Forrest & Company, Inc. and Pennsylvania-based BE Schneider Consulting, LLC. execute a strategic alliance agreement to offer clients expanded services in the field of pharmaceutical licensing.
March 6, 2012. B D Forrest & Company, Inc. executes pharmaceutical licensing agreement with Ancora Pharmaceuticals, Inc.
Nov. 12, 2010. B D Forrest & Company, Inc. executes pharmaceutical licensing agreement with Fluoropharma, Inc.
Aug. 31, 2010. B D Forrest & Company, Inc. executes a pharmaceutical licensing agreement with Adjuvance Technologies, Inc.
Consulting
April 27, 2016. B D Forrest & Company, Inc. executes agreement to provide consulting services to IHI Corporation and IHI Inc.
December 1, 2015. B D Forrest & Company, Inc. executes agreement to provide consulting services to Philip Morris International.
October 7, 2015. B D Forrest & Company, Inc. executes agreement to provide consulting services to NewLink Genetics Corp., Inc.
August 1, 2015. B D Forrest & Company, Inc. executes agreement to provide consulting services to Mitsubishi Tanabe Pharma Holdings America, Inc.
March 1, 2015. B D Forrest & Company, Inc. and RSC Statistical Consulting, LLC, execute a strategic alliance agreement to offer clients expanded services in the field of pharmaceutical & vaccine biostatistical consulting services.
February 10, 2015. B D Forrest & Company, Inc. executes agreement to provide consulting services to Genprex, Inc.
February 10, 2015. B D Forrest & Company, Inc. executes agreement to provide consulting services to Univac, NV.
February 1, 2015. B D Forrest & Company, Inc. and Green-Bio, LLC, execute a strategic alliance agreement to offer clients expanded services in the field of pharmaceutical & vaccine development consulting services.
January 30, 2015. B D Forrest & Company, Inc. executes agreement to provide consulting services to SutroVax, Inc.
January 5, 2015. B D Forrest & Company, Inc. executes agreement to provide consulting services to CuraVac, Inc.
January 1, 2015. B D Forrest & Company, Inc. and PharmaTegix, LLC, execute a strategic alliance agreement to offer clients expanded services in the field of pharmaceutical development and strategic marketing consulting services.
October 14, 2014. B D Forrest & Company, Inc. executes agreement to provide consulting services to Naturex-DBS, LLC.
October 4, 2014. B D Forrest & Company, Inc. and Glycoconjugate Technologies, LLC. execute a strategic alliance agreement to offer clients expanded services in the field of conjugate vaccine manufacturing and development consulting services.
July 28, 2014. B D Forrest & Company, Inc. executes agreement to provide consulting services to Affinivax, Inc.
May 1, 2014. B D Forrest & Company, Inc. announces the expansion of its consulting services with Omni Bio Pharmaceutical, Inc.; assuming an increased responsibility for the implementation of the development plan for Omni Bio Pharmaceutical's lead Fc fusion recombinant alpha-1 antitrypsin molecule through the role of Chief Development Officer. More information can be found in the Omni Bio Pharmaceutical's press release of May 1, 2014. B D Forrest & Company is dedicated to work with clients to flexibly develop solutions to a range of pharmaceutical, biopharmaceutical and vaccines' development challenges.
April 1, 2014. B D Forrest & Company, Inc. executes agreement to provide consulting services to Mitsubishi Tanabe Pharma Corp.
January 1, 2014. B D Forrest & Company, Inc. executes agreement to provide consulting services to Medicago, Inc.
January 1, 2014. B D Forrest & Company, Inc. and Bio/Vax, LLC. execute a strategic alliance agreement to offer clients expanded services in the field of pharmaceutical development consulting services.
September 1, 2013. B D Forrest & Company, Inc. executes agreement to provide consulting services to Lakewood Amedex, Inc.
August 1, 2013. B D Forrest & Company, Inc. executes agreement to provide consulting services to Baxter Healthcare Corporation.
July 1, 2013. B D Forrest & Company, Inc. executes agreement to provide consulting services to SynGlyco, Inc.
July 1, 2013. B D Forrest & Company, Inc. executes agreement to provide consulting services to Daiichi Sankyo Company Limited.
December 19, 2012. B D Forrest & Company, Inc. is contracted to provide pharmaceutical and business development services to Omni Bio Pharmaceutical, Inc.
June 14, 2012. B D Forrest & Company, Inc. executes pharmaceutical licensing agreement with Variation Biotechnologies, Inc.
Mar. 13, 2012. B D Forrest & Company, Inc. executes agreement to provide consulting services to HUYA Bioscience International, LLC.
Sep. 9, 2011. B D Forrest & Company, Inc. executes agreement to provide consulting services to Ancora Pharmaceuticals, Inc.
Apr. 22, 2011. B D Forrest & Company, Inc. executes agreement to provide consulting services to Nuron Pharmaceuticals, Inc.
Dec. 16, 2010. B D Forrest & Company, Inc. executes agreement to provide consulting services to Novartis BioVentures Ltd.
May 24, 2010. B D Forrest & Company, Inc. executes agreement to provide consulting services to the Program for Appropriate Technology in Health (PATH).
Apr. 6, 2010. B D Forrest & Company, Inc. executes agreement to provide consulting services to VaxInnate Corporation.
Some Agreements or Transactions cannot be disclosed due to client request for confidentiality.